Interventional pulmonology uses minimally invasive endoscopic and percutaneous procedures for diagnosis and staging of lung cancer and others neoplastic conditions. The last decades were characterized by a tremendous growth in this field, with the development of many advanced technical modalities which require training and expertise. The introduction of the lung screening lead to an increase in the incidental finding of pulmonary nodules and consequently to a growing requirement of tissue diagnosis.
This Research Topic aims to provide a comprehensive overview of recent advances in the bronchoscopic diagnosis of lung cancer. The collection will serve as a valuable resource and platform for pulmonologists, thoracic surgeons, and oncologists with the aim of improving outcomes for lung cancer patients. By highlighting the latest developments in bronchoscopy, this Research Topic will contribute to the early and accurate diagnosis of lung cancer, which is essential for successful treatment outcomes.
We welcome submissions of Original Articles, Case Reports, Clinical Trials, Case Studies, Mini Reviews, Opinions, Perspectives, Reviews, Study Protocols, and Systematic Reviews focusing on the newer technologies available for the diagnosis of lung cancer. Specifically, we encourage articles that highlight advancements in:
- endoscopic navigation systems for the diagnosis and treatment of peripheral pulmonary lesions,
- the use of endobronchial ultrasound (EBUS) for the diagnosis of mediastinal masses, adenopathies, and central tumors
- the potential of transesophageal bronchoscopic ultrasound-guided fine needle aspiration (EUS-B-FNA),
- the effectiveness of cryobiopsy in diagnosing endobronchial and peripheral lung tumors, as well as mediastinal adenopathies.
Please note: manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent clinical or patient cohort, or biological validation in vitro or in vivo, which are not based on public databases) are not suitable for publication in this journal.
Interventional pulmonology uses minimally invasive endoscopic and percutaneous procedures for diagnosis and staging of lung cancer and others neoplastic conditions. The last decades were characterized by a tremendous growth in this field, with the development of many advanced technical modalities which require training and expertise. The introduction of the lung screening lead to an increase in the incidental finding of pulmonary nodules and consequently to a growing requirement of tissue diagnosis.
This Research Topic aims to provide a comprehensive overview of recent advances in the bronchoscopic diagnosis of lung cancer. The collection will serve as a valuable resource and platform for pulmonologists, thoracic surgeons, and oncologists with the aim of improving outcomes for lung cancer patients. By highlighting the latest developments in bronchoscopy, this Research Topic will contribute to the early and accurate diagnosis of lung cancer, which is essential for successful treatment outcomes.
We welcome submissions of Original Articles, Case Reports, Clinical Trials, Case Studies, Mini Reviews, Opinions, Perspectives, Reviews, Study Protocols, and Systematic Reviews focusing on the newer technologies available for the diagnosis of lung cancer. Specifically, we encourage articles that highlight advancements in:
- endoscopic navigation systems for the diagnosis and treatment of peripheral pulmonary lesions,
- the use of endobronchial ultrasound (EBUS) for the diagnosis of mediastinal masses, adenopathies, and central tumors
- the potential of transesophageal bronchoscopic ultrasound-guided fine needle aspiration (EUS-B-FNA),
- the effectiveness of cryobiopsy in diagnosing endobronchial and peripheral lung tumors, as well as mediastinal adenopathies.
Please note: manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent clinical or patient cohort, or biological validation in vitro or in vivo, which are not based on public databases) are not suitable for publication in this journal.
